http://www.fpnotebook.com/
Central Diabetes InsipidusAka: Central DI
- Definition
- Antidiuretic Hormone (ADH) deficiency
- Pathophysiology
- Polyuria
- Decreased ADH release
- Permanent Polyuria
- Central lesion above median eminence
- Transient Polyuria
- Central lesion below median eminence
- ADH passes via hypothalamus to portal capillaries
- Results in ADH release below the median eminence
- Polyuria
- Etiology
- Idiopathic (30%)
- Autoimmune disease (common)
- Lymphocyte inflammation
- Pituitary stalk (thickened stalk on MRI)
- Posterior pituitary
- Anterior Pituitary deficiency
- Growth Hormone
- ACTH deficient
- Lymphocyte inflammation
- Familial Diabetes Insipidus (very rare)
- Point mutation in ADH precursor gene
- Precursor accumulates
- Toxicity to ADH synthesizing cells
- Enhancement within hypothalamus on MRI
- Point mutation in ADH precursor gene
- Autoimmune disease (common)
- Neurosurgery (Transsphenoidal)
- Results from Hypothalamus or Pituitary trauma
- Most common cause of polyuria post neurosurgery
- Differential Diagnosis
- Excess fluids
- Mannitol
- Corticosteroids
- Approach
- Check Urine Osmolality
- Observe response to water restriction
- Malignancy
- Examples: Lung Cancer, Leukemia, Lymphoma
- Polyuria may be presenting symptom
- Langerhans Histiocytosis (Histiocytosis X)
- Infiltrative disease
- Sarcoidosis causes similar infiltration
- Post SVT resolution
- Anorexia Nervosa
- Pregnancy exacerbates any of above forms
- Idiopathic (30%)
- Diagnosis
- Fluid Deprivation Test
- No response to water deprivation
- Response to exogenous ADH administration
- Hare-Hickey Test
- Decreased ADH to Serum Osmolality ratio
- Fluid Deprivation Test
- Radiology: MRI Head
- Central DI: Diminished signal at posterior pituitary
- Management
- General Measures that potentiate ADH
- Low sodium diet
- NSAIDs
- dDAVP (Desmopressin)
- Synthetic ADH replacement hormone
- dDAVP 10 to 20 ug bid intranasally
- Chlorpropamide 125-250 mg PO qd-bid
- Antidiuretic effect - may lower Urine output by 50%
- Risk of Hypoglycemia at higher doses
- Carbamazepine 100-300 mg bid
- Enhances ADH response
- May lower urine output by 50%
- Hydrochlorothiazide with low salt intake
- Decreases polyuria
- Dose: 25 mg qd to bid
- General Measures that potentiate ADH
Central Diabetes Insipidus (C0687720) | |
|---|---|
| Definition (MSH) | A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS). |
| Concepts | Disease or Syndrome (T047) |
| ICD9 | 253.5 |
| MSH | D020790 |
| English | antidiuretic hormone defective syndrome, Central Diabetes Insipidus, Cranial diabetes insipidus, Diabetes insipidus - pituitary, Diabetes insipidus secondary to vasopressin deficiency, Neurogenic diabetes insipidus, Neurohypophyseal diabetes insipidus, Pituitary diabetes insipidus, Primary central diabetes insipidus, vasopressin defective diabetes insipidus, Vasopressin deficiency, Vasopressin deficiency syndrome |
| Spanish | diabetes insipida craneal, diabetes insipida neurogenica, diabetes insipida neurohipofisaria, diabetes insipida pituitaria, diabetes insipida primaria central, diabetes insipidus secundaria a deficiencia de vasopresina, sindrome de deficiencia de vasopresina |
| Parent Concepts | Diabetes Insipidus (C0011848), Duplicate concept (C1274013), Ambiguous concept (C1274012) |
| Sources | CSP, DXP, MSH, MTH, MTHICD9, NDFRT, OMIM, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
